Lbp Am Sa Sells 8,014 Shares of Zoetis Inc. (NYSE:ZTS)

LBP AM SA cut its holdings in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 7.1% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 104,787 shares of the company's stock after selling 8,014 shares during the period. LBP AM SA's holdings in Zoetis were worth $17,253,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Brighton Jones LLC increased its stake in shares of Zoetis by 180.4% in the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company's stock valued at $754,000 after acquiring an additional 2,978 shares during the last quarter. Bank Pictet & Cie Europe AG raised its holdings in Zoetis by 5.4% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 419,530 shares of the company's stock worth $68,354,000 after buying an additional 21,470 shares during the period. Proficio Capital Partners LLC raised its holdings in Zoetis by 61.0% during the 4th quarter. Proficio Capital Partners LLC now owns 3,053 shares of the company's stock worth $497,000 after buying an additional 1,157 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Zoetis by 5.9% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 217,094 shares of the company's stock worth $35,371,000 after buying an additional 12,174 shares during the period. Finally, Daiwa Securities Group Inc. raised its holdings in Zoetis by 4.7% during the 4th quarter. Daiwa Securities Group Inc. now owns 75,874 shares of the company's stock worth $12,362,000 after buying an additional 3,421 shares during the period. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have commented on ZTS shares. Piper Sandler raised their target price on shares of Zoetis from $205.00 to $210.00 and gave the stock an "overweight" rating in a report on Monday, May 12th. UBS Group decreased their price target on shares of Zoetis from $189.00 to $170.00 and set a "neutral" rating for the company in a research note on Wednesday, May 7th. Finally, Stifel Nicolaus cut shares of Zoetis from a "buy" rating to a "hold" rating and decreased their price target for the stock from $165.00 to $160.00 in a research note on Wednesday, June 18th. Two analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $212.13.

Zoetis Trading Down 2.4%

Shares of Zoetis stock traded down $3.89 on Friday, reaching $154.91. 2,267,443 shares of the company's stock were exchanged, compared to its average volume of 2,591,359. The company has a market capitalization of $68.97 billion, a P/E ratio of 27.81, a price-to-earnings-growth ratio of 2.63 and a beta of 0.91. Zoetis Inc. has a 52 week low of $139.70 and a 52 week high of $200.33. The firm's 50-day moving average is $161.32 and its two-hundred day moving average is $161.86. The company has a debt-to-equity ratio of 1.12, a quick ratio of 1.04 and a current ratio of 1.74.

Zoetis (NYSE:ZTS - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.40 by $0.08. Zoetis had a return on equity of 55.48% and a net margin of 27.12%. The company had revenue of $2.22 billion for the quarter, compared to analysts' expectations of $2.20 billion. During the same period last year, the business earned $1.38 EPS. Zoetis's quarterly revenue was up 1.4% compared to the same quarter last year. Sell-side analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 3rd. Shareholders of record on Friday, July 18th will be given a $0.50 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.00 annualized dividend and a yield of 1.29%. Zoetis's payout ratio is currently 35.91%.

Insiders Place Their Bets

In other news, EVP Roxanne Lagano sold 652 shares of the business's stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total transaction of $110,840.00. Following the transaction, the executive vice president directly owned 15,129 shares of the company's stock, valued at approximately $2,571,930. The trade was a 4.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.18% of the company's stock.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.